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Summary
 
How strong adjuvants such as complete Freund’s adjuvant (CFA) promote T cell priming to
protein antigens in vivo is still unclear. Since the unmethylated CpG motifs in DNA of bacteria
and other nonvertebrates are stimulatory for B cells and antigen-presenting cells, the strong ad-
juvanticity of CFA could be attributed, at least in part, to the presence of dead bacteria, i.e., a
source of stimulatory DNA. In support of this possibility, evidence is presented that insect
DNA in mineral oil has even stronger adjuvant activity than CFA by a number of parameters.
Synthetic oligodeoxynucleotides (ODNs) containing unmethylated CpG motifs mimic the ef-
fects of insect DNA and, even in soluble form, ODNs markedly potentiate clonal expansion of
T cell receptor transgenic T cells responding to specific peptide.
 
I
 
t is now well established that unmethylated CpG dinu-
cleotide motifs of bacterial DNA have the capacity to
cause polyclonal activation of B cells and stimulation of
APCs (1–8). The immunostimulatory property of unmeth-
ylated CpG motifs is not unique to bacteria and applies to a
wide spectrum of nonvertebrates including insects, nema-
todes, mollusks, and yeast (3, 9, 10); by contrast, DNA
from various vertebrates, e.g., frogs and fish, is nonstimula-
tory. The capacity of nonvertebrate DNA to stimulate B
cells and APCs is shared by synthetic oligodeoxynucleotides
(ODNs) containing unmethylated CpG motifs (5, 11). When
coinjected with antigen, these agents also enhance the gen-
eration of cytotoxic T cell activity and production of spe-
cific antibody and IFN-
 
g
 
 (12–15).
Stimulation of APCs via unmethylated CpG motifs
could explain the remarkable efficacy of “naked” DNA
vaccines (16). In this respect, the induction of antigen-spe-
cific responses after DNA vaccination is reported to be
much more efficient when the plasmid vector for mamma-
lian DNA contains unmethylated CpG motifs (17, 18). In
light of this finding, DNA vaccines may operate not only
by providing a source of specific antigen (peptide) but by
acting as an adjuvant, i.e., by enhancing the immunogenic-
ity of APCs. According to this notion, the poor immuno-
genicity of proteins or peptides given in solution could be
overcome simply by coinjecting any source of DNA con-
taining stimulatory CpG motifs. In support of this predic-
tion we show here that, when suspended in mineral oil, in-
sect DNA and ODNs containing unmethylated CpG
motifs act as powerful adjuvants in mice when coinjected
with foreign peptides or proteins. ODNs also have adju-
vant activity in soluble form and markedly amplify clonal
expansion of TCR transgenic T cells responding to specific
peptide.
 
Materials and Methods
 
Mice.
 
C57BL/6J (B6) mice were purchased from The Jack-
son Laboratory (Bar Harbor, ME). 2C TCR transgenic mice (9)
were bred and maintained at The Scripps Research Institute (La
Jolla, CA).
 
Proteins and Peptides.
 
Fowl 
 
g
 
-globulin (F
 
g
 
G) was purchased
from Pel-Freez Biologicals (Rogers, AR). A synthetic peptide,
SIYRYYGL (19), recognized by 2C TCR transgenic cells in the
context of H-2K
 
b
 
 was provided by Z. Cai (R.W. Johnson Phar-
maceutical Research Institute, San Diego, CA). This peptide was
synthesized on a synthesizer (431 A; Applied Biosystems, Foster
City, CA) and purified with C18 reverse-phase high performance
liquid chromatography.
 
DNA and ODNs.
 
DNA from the 
 
Drosophila melanogaster
 
 cell
line, SC2, was prepared as described (20). For injection, DNA
was used without denaturation. CpG (GCATGACGTTGA-
GCT) and ZpG (GCATGAZGTTGAGCT, Z 
 
5
 
 5
 
9
 
-methyl-C)
phosphorothioated ODNs were designed using published se-
quences (5). The ODNs were synthesized and purified using
HPLC by Research Genetics, Inc. (Huntsville, AL). Residual
LPS in DNA preparations was measured (Limulus Amebocyte
Lysate QCL-1000 kit; BioWhittaker, Walkersville, MD). 
 
D. me-
lanogaster
 
 DNA preparations contained 0–10 pg of LPS/mg of
DNA.
 
Immunization with F
 
g
 
G and antibody production.
 
Mice were in-
jected subcutaneously with F
 
g
 
G 
 
6
 
 adjuvant in the lower portion
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of both hind limbs in a volume of 50 
 
m
 
l/limb. For injection, F
 
g
 
G
was either (
 
a
 
) suspended in saline with soluble insect DNA or
ODNs, or (
 
b
 
) mixed with CFA or IFA (mineral oil) plus either
insect DNA or ODNs; in each situation, the dose of F
 
g
 
G in-
jected was the same. Specific antibody production was deter-
mined by coating 96-well flat-bottomed plates with 2 
 
m
 
g F
 
g
 
G/
well. Serially diluted antiserum were allowed to bind to the
plates, washed, and then detected with isotype-specific biotiny-
lated antibodies and streptavidin–horseradish peroxidase (Phar-
Mingen, San Diego, CA).
 
In Vitro T Proliferation Assay and IFN-
 
g
 
 Production.
 
To measure
proliferative responses to F
 
g
 
G, draining (popliteal) LN cells from
F
 
g
 
G-primed mice were removed at day 9 after priming and then
cultured with the indicated concentration of F
 
g
 
G in 200 
 
m
 
l vol-
umes in 96-well plates using standard tissue culture medium plus
FCS (21); in some experiments, B cell–depleted LN cells or puri-
fied LN CD4
 
1
 
 cells (21) were used as responders. To measure
proliferation, cultures were harvested on day 4 after overnight ad-
dition of 1 
 
m
 
Ci [
 
3
 
H] thymidine (TdR). To measure IFN-
 
g
 
 pro-
duction, aliquots of culture supernatants were collected on day 2
or 3; IFN-
 
g
 
 production was measured with an ELISA assay using
anti–IFN-
 
g
 
 mAbs from PharMingen.
 
Adoptive Transfer, Immunization, and In Vivo Proliferation of TCR
Transgenic T Cells.
 
For adoptive transfer, doses of 2 
 
3
 
 10
 
7
 
 un-
separated spleen plus LN cells from 2C mice on a B6 background
were injected intravenously into normal B6 mice. The recipients
were then injected subcutaneously with peptide 
 
6
 
 soluble ODNs
in both hind limbs. To measure proliferation in vivo, groups of
the recipients were given a single injection of 1 mg bromode-
oxyuridine (BrdU) intraperitoneally at 3, 4, or 5 d after immuni-
zation; BrdU incorporation was measured 4 h after BrdU injection.
 
Cell Surface Staining and Flow Cytometry.
 
As described else-
where  (22), cell suspensions were first surface stained for expres-
sion of CD8 and the TCR clonotype of 2C cells, detected by
1B2 mAb (23). After fixation, the cells were then stained inter-
nally for BrdU incorporation using an anti-BrdU mAb (Becton
Dickinson, San Jose, CA). Stained cells were analyzed on a FAC-
Scan
 
Ò
 
 flow cytometer.
 
Results
 
In previous studies, the effects of SssI methylase treat-
ment indicated that the capacity of insect (
 
D. melanogaster
 
)
DNA to cause polyclonal activation of B cells was con-
trolled, at least in part, by unmethylated CpG motifs (9).
To test whether insect DNA could act as an adjuvant for
antigen-specific T cell responses, mice were injected sub-
cutaneously with F
 
g
 
G mixed with insect DNA (100 
 
m
 
g/
mouse); since DNA is highly unstable when injected in
vivo, some mice received F
 
g
 
G plus insect DNA suspended
in IFA. Control mice received F
 
g
 
G in saline or suspended
in CFA or in IFA without DNA.
 
Adjuvant Effect of Insect DNA on Normal CD4
 
1
 
 T Cells.
 
Priming of mice injected with F
 
g
 
G 
 
6
 
 adjuvant was mea-
sured by removing the draining LN (DrLN) at 9 d after im-
munization and culturing LN cell suspensions with or
without F
 
g
 
G in vitro. The results of culturing either un-
separated LN cells or purified CD4
 
1
 
 cells with F
 
g
 
G are
shown in Fig. 1 
 
A.
 
 As expected, for both cell populations,
in vitro T proliferative responses to F
 
g
 
G were substantial
with in vivo priming to F
 
g
 
G in CFA and somewhat lower
with priming in IFA. When mice were primed with F
 
g
 
G
in saline alone (not shown) or with F
 
g
 
G plus soluble insect
DNA (Fig. 1 
 
A
 
), secondary responses to F
 
g
 
G in vitro were
virtually undetectable, indicative of minimal immunization.
In marked contrast, priming with F
 
g
 
G plus insect DNA
suspended in IFA led to strong secondary responses to F
 
g
 
G
in vitro. Significantly, these responses were appreciably
Figure 1. Adjuvant function of insect DNA for T cell responses to
FgG. Normal B6 mice were immunized in the hind limbs with FgG (25
mg/limb for A, top and B, 5 mg/limb for A, bottom) mixed with CFA,
IFA, DNA, or IFA and DNA; for DNA, insect DNA was injected at 50
mg/limb. Cell suspensions were prepared from the DrLN 9 d later. For A,
top and B, unseparated LN cells were cultured at 2.5 3 105 cells/well 6
FgG (20 mg/well, 100 mg/ml). For A, bottom, purified CD41 cells were
prepared from DrLN cells and cultured at 105/well in the presence of
T-depleted spleen cells (4 3 105/well) 6 FgG (10 mg/ml). To measure
[3H]TdR incorporation (A), cultures were pulsed with 1 mCi/well of
[3H]TdR on day 3 and harvested for radioactive counting on day 4. For
IFN-g production (B), supernatants were tested on day 3. The data show
means of triplicate cultures; SDs were within 10–20% of the means. 
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higher than with priming to F
 
g
 
G in CFA. Similar results
occurred for production of IFN-
 
g
 
 in vitro (Fig. 1 
 
B
 
) and
also for production of specific Ab (see below). As a nega-
tive control for insect DNA, we used DNA from nonver-
tebrates (salmon testes; reference 10). In contrast to insect
DNA, salmon DNA in IFA plus F
 
g
 
G was no more immu-
nogenic than IFA plus F
 
g
 
G alone (data not shown).
 
Adjuvant Effect of Synthetic ODNs on Normal T Cells.
 
The above data indicate that insect DNA acts as a powerful
adjuvant, though only when suspended in IFA. To assess
whether the adjuvanticity of DNA is controlled by unmeth-
ylated CpG motifs, we prepared two synthetic 15-mer
ODNs containing a single CG dinucleotide pair. The only
difference between the two ODNs was that, for the CG
pair, C was unmethylated for one ODN (CpG ODN) but
methylated (ZpG ODN) for the other; to retard degrada-
tion in vivo, both ODNs contained a phosphorothioated
backbone.
To assess adjuvanticity, mice were primed with F
 
g
 
G plus
50 
 
m
 
g/mouse of CpG or ZpG ODNs suspended either in
IFA or saline. As measured by secondary T proliferative re-
sponses in vitro to graded concentrations of F
 
g
 
G (Fig. 2 
 
A
 
,
 
left
 
), priming with F
 
g
 
G in IFA was considerably augmented
by addition of CpG ODNs; by contrast, addition of ZpG
ODNs to IFA had no effect. Thus, for ODNs in IFA, only
CpG and not ZpG ODNs had demonstrable adjuvant ac-
tivity (relative to priming in IFA alone). The results were
quite similar for IFN-
 
g
 
 production, except that, for this as-
say, F
 
g
 
G priming with IFA plus ZpG was clearly higher
than with IFA alone (Fig. 2 B, left). In general, FgG prim-
ing with IFA and CpG ODNs was substantially more effec-
tive than priming with CFA, especially for IFN-g produc-
tion (Fig. 2 B, left, and data not shown).
The above data refer to ODNs suspended in IFA. Signif-
icantly, in contrast to soluble insect DNA, CpG ODNs in
saline displayed quite strong adjuvant activity for T prolif-
erative responses (Fig. 2 A, right); by contrast, ZpG ODNs
in saline were ineffective. For IFN-g production, priming
with CpG ODNs in saline led to much lower responses
than with CpG ODNs in IFA (Fig. 2 B). Nevertheless,
IFN-g production elicited by ODNs in saline was clearly
demonstrable with CpG ODNs, but undetectable with
ZpG ODNs (Fig. 2 B, right).
Confirming the results of others (12–15), CpG ODNs
acted as a powerful adjuvant for specific Ab production
(Fig. 2 C). In saline (Fig. 2 C, left), CpG ODNs augmented
both IgM and IgG Ab to FgG; except for IgG1 Ab, ZpG
ODNs were much less effective. Addition of IFA consider-
ably augmented the adjuvant activity of CpG (but not
ZpG) ODNs, especially for IgG2a (Fig. 2 C, right), IgG2b,
and IgG3 (data not shown) Ab. For these isotypes, Ab pro-
duction elicited by CpG ODNs in IFA was substantially
higher than with CFA immunization (Fig. 2 C, right); simi-
lar findings occurred with insect DNA in IFA (Fig. 2 C,
right). By contrast, CpG ODNs or insect DNA in IFA in-
hibited the production of IgG1 Ab, relative to immuniza-
tion with CFA or IFA alone (data not shown). Signifi-
cantly, the adjuvant activity of CpG ODNs required
coinjection with FgG in the same site. Thus, injection of
CpG ODNs in the front limbs and FgG in the hind limbs
failed to elicit Ab production (Fig. 2 C, left).
Adjuvant Effects of ODNs on TCR Transgenic CD81
Cells. Since adjuvants presumably act largely by augment-
ing the clonal expansion of antigen-specific T cells, we
sought direct evidence on this issue by studying the capac-
ity of ODNs to augment proliferation of TCR transgenic
T cells to specific peptide in vivo. For these studies we used
2C TCR transgenic mice. For this line, CD81 T cells have
strong reactivity for a synthetic peptide, SIYRYYGL (19),
presented by self (Kb) class I molecules. Using 2C mice on
a B6 background, the approach taken (24) was to transfer
doses of 2 3 107 2C lymphoid cells (pooled from spleen
and LN) intravenously into normal B6 mice and then inject
the mice subcutaneously with specific peptide 6 CpG or
ZpG ODNs in saline. To measure T cell proliferation in
vivo, groups of the recipients were injected with the DNA
Figure 2. Adjuvant function of ODNs for T cell responses to FgG.
Mice were immunized to FgG (5 mg/limb) as described for Fig. 1, using
CpG and ZpG ODNs (25 mg/limb) instead of DNA; ODNs were either
mixed with IFA (A; B, left; and C, right) or suspended in saline (A; B,
right; and C, left). Antiserum was collected by tail bleeding on day 9 and
tested at 1:100 or 1:1,000 dilution (C). For Ab production, some mice re-
ceived CpG ODNs in the front limbs and FgG in the hind limbs (FgG 1
CpG*). For in vitro responses (A and B), DrLN cells were removed on
day 9, depleted of B cells, and cultured with graded doses of FgG for 3 d
(IFN-g production) or 4 d ([3H]TdR incorporation). The data show
means of triplicate cultures. Two other experiments gave similar findings.1148 DNA as an Adjuvant
precursor, BrdU, at 3, 4, or 5 d after immunization; 4 h af-
ter BrdU injection, cell suspensions were stained for surface
markers and then, after fixation, for BrdU incorporation.
This 4-h pulse approach (22) thus provided an indication of
the extent of donor cell proliferation at daily intervals from
days 3 through 5. Donor CD81 cells were detected by
staining for expression of CD8 and the 2C TCR clono-
type, 1B2.
As shown in Fig. 3 A, left, total numbers of donor CD81
cells (1B21 CD81 cells) in the DrLN were substantially
higher after injection of peptide and CpG ODNs than with
injection of peptide alone; ZpG ODNs were much less ef-
fective. Similar findings applied to donor cell proliferation,
i.e., to total numbers of BrdU1 1B21 CD81 cells in the
DrLN (Fig. 3 B, left).
These data refer to the response of donor CD81 cells in
the DrLN. Surprisingly, injecting peptide plus CpG ODNs
caused a marked increase in total numbers of both 1B21
CD81 cells (Fig. 3 A, right) and BrdU1 1B21 CD81 cells
(Fig. 3 B, left) in the spleen, though not in mesenteric LN
(MLN). By contrast, injection of peptide alone or peptide
plus ZpG ODNs caused little, if any, evidence of prolifera-
tion in the spleen.
A rough estimate of the extent of donor T cell prolifera-
tion in the whole animal was obtained by calculating total
numbers of BrdU1 1B21 CD81 cells in DrLN 1 MLN 1
spleen at days 3 through 5. By this parameter, priming with
peptide plus CpG ODNs was far more effective than prim-
ing with peptide alone (Fig. 3 B, right); priming with pep-
tide plus ZpG ODNs was only slightly better than with
peptide alone.
Discussion
Since CFA has long been the “gold standard” for adju-
vant function, it is of interest that the adjuvant activity of
insect DNA in mineral oil (IFA) surpassed the activity of
CFA by three different parameters, namely T proliferative
responses, IFN-g synthesis, and production of specific Ab.
This finding supports the view that the adjuvant activity of
CFA is due, at least in part, to the presence of dead bacte-
ria, a source of immunostimulatory DNA (3).
It should be emphasized that insect DNA only displayed
adjuvant activity when suspended in mineral oil; in soluble
form, insect DNA was ineffective, presumably reflecting
rapid degradation by enzymes. In view of this problem, we
resorted to the use of phosphorothioate-modified synthetic
ODNs, which are comparably resistant to degradation in
vivo (5). Except for CpG methylation, the two ODNs
studied were identical. Confirming the findings of others
(5), preliminary data established that CpG ODNs were
highly effective in stimulating B cell proliferation in vitro,
whereas ZpG ODNs had minimal activity (our unpub-
lished data). Significantly, this marked difference between
CpG and ZpG ODNs also applied to adjuvant activity.
Thus, unlike ZpG ODNs, CpG ODNs acted as a strong
adjuvant when used to prime mice for T proliferative re-
sponses, IFN-g synthesis, and production of specific Ab to
FgG. Although the adjuvant activity of CpG ODNs was
clearly much higher when suspended in IFA, priming in
the presence of soluble CpG ODNs led to quite strong T
proliferative responses and low but significant production
of specific Ab and IFN-g. Confirming previous findings
(12–15), the adjuvant activity of CpG ODNs for Ab pro-
duction was much more prominent for certain Ig isotypes,
e.g., IgG2a, than for others, notably IgG1; similar findings
applied to insect DNA. Thus, for synthetic ODNs and
DNA, the adjuvant function of CpG motifs appears to be
skewed to Th1 function (12–15).
Examining the influence of adjuvants during the early
primary response is difficult in normal mice, but relatively
easy in TCR transgenic mice. When TCR transgenic T
cells are exposed to specific peptide on adoptive transfer, it
is well established that a mixture of peptide in CFA leads to
a prolonged proliferative response (24); by contrast, injec-
tion of peptide alone elicits only transient proliferation fol-
lowed by rapid elimination of the responding T cells. In
line with these findings, the response of 2C CD81 cells to
specific peptide alone was very brief and declined abruptly
after day 3. By contrast, supplementing peptide with solu-
Figure 3. Capacity of ODNs to augment clonal expansion of 2C trans-
genic CD81 cells responding to specific peptide. Groups of B6 mice were
injected intravenously with 2 3 107 2C lymphoid cells and then injected
subcutaneously in the hind limbs with specific peptide (25 mg/limb) 6
soluble CpG or ZpG ODNs (25 mg/limb). At 3, 4, or 5 d after immuni-
zation, the mice received a single intraperitoneal injection of 1 mg BrdU.
Lymphoid organs were removed from the mice 4 h later and cell suspen-
sions were stained for CD8 and 1B2 expression and then for BrdU incor-
poration followed by FACSÒ analysis. The data show mean values (2–3
mice/group) for total numbers of 1B21 CD81 cells (A) and BrdU1 1B21
CD81 cells (B) in the DrLN, spleen, and MLN. Essentially identical re-
sults were seen in a second experiment.1149 Sun et al. Brief Definitive Report
ble CpG ODNs augmented and considerably prolonged
the proliferative response, indicative of an adjuvant effect.
Rather surprisingly, the proliferative response elicited by
peptides plus CpG ODNs involved not only the DrLN but
also the spleen. Yet proliferation in MLNs was undetect-
able. How can this distribution be explained? The simplest
possibility in our view is that, in contrast to peptide alone,
exposure to peptide plus ODNs in the DrLN signaled the
responding T cells to survive and make their way into the
circulation, thus reaching the spleen. The failure of the cells
to reach MLNs may have reflected that antigen activation
of T cells often leads to downregulation of the LN homing
receptor, CD62L (25), thus preventing migration to LN
but not to spleen. In fact, in more recent studies, a high
proportion (50%) of the 1B21 CD81 cells in the spleen on
day 4 were CD62Llo (data not shown); such downregula-
tion of CD62L did not apply to MLNs and, in spleen, was
only seen with injection of peptide plus CpG ODNs.
How DNA and ODNs potentiate clonal expansion of
antigen-specific T cells in vivo is still unclear. Others have
postulated that ODNs act directly on T cells and provide a
second signal for cells subjected to TCR ligation (12). The
alternative possibility is that ODNs function largely by po-
tentiating APC function, e.g., by inducing synthesis of cy-
tokines such as IL-1, TNF-a, and IL-6 (6, 7, 26, 27), thus
causing migration of APCs to DrLN (28), and perhaps also
by stimulating upregulation of costimulatory molecules on
APC precursors, e.g., by IFN-I (15, 29, and our unpub-
lished data). However, direct evidence on the mechanism
of action of ODNs under in vivo conditions is still unavail-
able.
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